DIA456.09-0.70 -0.15%
SPX6,460.26-41.60 -0.64%
IXIC21,455.55-249.61 -1.15%

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga·08/18/2025 12:08:41
Listen to the news

Gainers

  • Propanc Biopharma (NASDAQ:PPCB) stock rose 104.5% to $5.87 during Monday's pre-market session. The market value of their outstanding shares is at $33.3 million.
  • Adaptimmune Therapeutics (NASDAQ:ADAP) stock moved upwards by 52.1% to $0.09. The market value of their outstanding shares is at $15.7 million. As per the news, the Q2 earnings report came out 3 days ago.
  • Soligenix (NASDAQ:SNGX) stock moved upwards by 44.96% to $4.03. The market value of their outstanding shares is at $9.0 million. As per the news, the Q2 earnings report came out 2 days ago.
  • DIH Holding US (NASDAQ:DHAI) shares rose 29.86% to $0.31. The market value of their outstanding shares is at $11.3 million.
  • BioXcel Therapeutics (NASDAQ:BTAI) shares rose 28.64% to $7.05. The market value of their outstanding shares is at $79.7 million. As per the news, the Q2 earnings report came out 4 days ago.
  • Genfit (NASDAQ:GNFT) shares rose 15.78% to $4.62. The market value of their outstanding shares is at $199.5 million.

Losers

  • CASI Pharmaceuticals (NASDAQ:CASI) shares declined by 16.0% to $2.0 during Monday's pre-market session. The market value of their outstanding shares is at $36.8 million.
  • Matinas BioPharma Hldgs (AMEX:MTNB) stock decreased by 13.99% to $2.03. The market value of their outstanding shares is at $12.0 million.
  • PolyPid (NASDAQ:PYPD) shares declined by 13.63% to $2.98. The market value of their outstanding shares is at $35.1 million. As per the press release, Q2 earnings came out 3 days ago.
  • Vyome Holdings (NASDAQ:HIND) stock decreased by 13.51% to $12.11. The market value of their outstanding shares is at $369.1 million.
  • Tivic Health Systems (NASDAQ:TIVC) stock decreased by 13.46% to $3.28. The company's market cap stands at $3.9 million. As per the news, the Q2 earnings report came out 2 days ago.
  • Inhibikase Therapeutics (NASDAQ:IKT) stock fell 12.0% to $1.54. The market value of their outstanding shares is at $130.0 million. As per the press release, Q2 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.